Recruitment of consultant firm to design, supervise and commissioning of the vaccine manufacturing building construction

Source: World Bank — Ethiopia COVID-19 Emergency Response

REQUEST FOR EXPRESSION OF INTEREST (REOI)

(CONSULTING SERVICES – FIRMS SELECTION)

Country: Federal Democratic Republic of Ethiopia

Name of Project: Ethiopia COVID-19 Emergency Response 2nd Additional Financing

Loan No /Credit No./Grant No.:IDA-D7910

Assignment Name: Consultancy for Feasibility studies, Bidding Document, Detailed engineering design, human resource development plan and technology transfer, supervision and advisory services for the establishment of cGMP compliant vaccine, diagnostics and pharmaceuticals manufacturing capacity in Ethiopia

Reference No. ET-MOH- 343852-CS-QCBS

The Federal Democratic Republic of Ethiopia has received financing from the World Bank for COVID-19 Emergency Response 2nd Additional Financing and intends to apply part of the proceeds for procurement of Consultancy service for Feasibility studies, Bidding Document, Detailed engineering design, human resource development and technology transfer, supervision and advisory services for the establishment of cGMP compliant vaccine, diagnostics and pharmaceuticals manufacturing capacity in Ethiopia.

The consulting services (“the Services”) include the updating existing vaccine feasibility study, Design and Supervision of Construction, the Construction Documents including biding documents, the Construction Management and the Post-Construction Monitoring of cGMP compliant vaccine manufacturing facility and new feasibility studies for diagnostics and pharmaceuticals manufacturing capacity in Ethiopia. The consultant should have experience in designing, supervising cGMP compliant vaccine, diagnostics and pharmaceuticals manufacturing construction, commissioning, testing, equipping, validation, verification, handover and sufficient consulting experience in low resource settings and transfer of knowledge to local vaccine, diagnostics and pharmaceuticals operators to get the vaccine manufacturing sustainable. All this experience is essential for the long-lasting success of the project. It is highly recommended that the firm narrowly follows the planning, design and construction manuals described in Terms of Reference (TOR). The detailed TOR for the assignment can be obtained at the address given below.  The estimated implementation period for Feasibility update, site investigation, design work, price study and tender document preparation is 120 days (4 months) and Supervision and Contract Administration Services including commissioning, testing, equipping, validation, verification, handover is 24 months; Defects Liability Period is 12 months with the overall assignment duration estimated as 40 months.

The Federal Ministry of Health now invites eligible consulting firms (“Consultants”) to indicate their interest in providing the Services. Interested Consultants should provide information demonstrating that they have the required qualifications and relevant experience to perform the Services. The short listing criteria are core business and years in business, relevant experience in cGMP compliant vaccine, diagnostics and pharmaceuticals manufacturing, technical and managerial capability of the firm. The Qualifications and Experience of Key Experts shall not be included in the short listing criteria. Key Experts will not be evaluated at the short listing stage.

The attention of interested Consultants is drawn to Section III, paragraphs, 3.14, 3.16, and 3.17 of the World Bank’s “Procurement Regulations for IPF Borrowers” November 2020 (“Procurement Regulations”), setting forth the World Bank’s policy on conflict of interest. 

In addition, please refer to the following specific information on conflict of interest related to this assignment: as per paragraph 3.17 of the Procurement Regulations.

Consultants may associate with other firms to enhance their qualifications but should indicate clearly whether the association is in the form of a joint venture and/or a sub-consultancy. In the case of a joint venture, all the partners in the joint venture shall be jointly and severally liable for the entire contract, if selected.

A Consultant will be selected in accordance with the Quality and Cost Based Selection (QCBS) method set out in the Procurement Regulations.

Further information can be obtained at the address below during office hours at the morning from 09:00 am to 12:30 pm and in the afternoon from 01:30 pm to 05:00 pm at the address stated below.

Expressions of interest must be delivered in a written form to the address below on or before July 26, 2023 at 2:30PM.  in person, or by e-mail or by any electronically application, either in hard copy, soft copy or both. The soft copy version, which should be a scan copy of the original signed proposal with all signing details, signatures and stamps fully visible, must be submitted along with a copy able / searchable PDF, or Word versions of proposals on a CD or an USB in the address below.

Ministry of Health

Procurement Executive Officer

P.O. Box 1234

Wereda: LidetaSubcity , Kebele __07/14_ House : Sudan Street

City:Addis Ababa,  Country: Ethiopia

Tel. Landline: +251-11-515 0993/

Procurement expert, Mr. Ashenafi Eshetu

Email: ashenafi.eshetu@moh.gov.et /gameolani72@gmail.com/berhan.alemneh@moh.gov.et